LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning and late Tuesday:
----------
FTSE 100
----------
S&P CAPITAL IQ RAISES BG GROUP TO 'HOLD' ('SELL') - PRICE TARGET 1050 PENCE
----------
BARCLAYS CUTS BG GROUP PRICE TARGET TO 1300 (1350) PENCE - 'EQUAL WEIGHT'
----------
UBS RAISES ITV PRICE TARGET TO 230 (210) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS PETROFAC PRICE TARGET TO 1250 (1340) PENCE
----------
UBS CUTS STANDARD CHARTERED PRICE TARGET TO 1120 (1315) PENCE - 'BUY'
----------
GOLDMAN CUTS STANDARD CHARTERED PRICE TARGET TO 1130 (1240) PENCE - 'NEUTRAL'
----------
TRADERS: NOMURA CUTS STANDARD CHARTERED TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS STANDARD CHARTERED PRICE TARGET TO 1000 (1260) PENCE - UNDERPERFORM
----------
HSBC CUTS STANDARD CHARTERED PRICE TARGET TO 950 (1150) PENCE - 'UNDERWEIGHT'
----------
NUMIS CUTS STANDARD CHARTERED PRICE TARGET TO 1000 (1200) PENCE - 'HOLD'
----------
CHARLES STANLEY CUTS STANDARD CHARTERED TO HOLD (ACCUMULATE) - TARGET 1150 (1400) PENCE
----------
Deutsche Bank Cuts Standard Life Price Target To 445p From 455p, Buy
----------
MORGAN STANLEY RAISES ANGLO AMERICAN PRICE TARGET TO 1500 (1440) PENCE - 'UNDERWEIGHT.'
----------
LBBW CUTS BP PRICE TARGET TO 520 (550) PENCE - 'BUY'
----------
TRADERS: BERNSTEIN RAISES ROLLS-ROYCE TO 'MARKET-PERFORM' ('UNDERPERFORM')
----------
FTSE 250
----------
CREDIT SUISSE CUTS AMEC PRICE TARGET TO 1070 (1150) PENCE
----------
CREDIT SUISSE CUTS JOHN WOOD PRICE TARGET TO 790 (890) PENCE
----------
LIBERUM RAISES BELLWAY PRICE TARGET TO 1990 (1764) PENCE - 'BUY'
----------
EXANE BNP CUTS SYNTHOMER PRICE TARGET TO 205 (215) PENCE - 'NEUTRAL'
----------
HSBC CUTS SYNTHOMER PRICE TARGET TO 220 (230) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 275 (314) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
BARCLAYS RAISES VECTURA GROUP PRICE TARGET TO 175 (171) PENCE - 'OVERWEIGHT'
----------
JEFFERIES CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 242 (300) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
18 Dec 2020 08:12
Hikma rallies as it launches generic version of Glaxo asthma treatment
(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.
Read more